key: cord-0726097-0nyzw3lw
authors: Yu, Xianqiang
title: Potential Value of Electroacupuncture in the Treatment of Gastrointestinal Symptoms of COVID-19
date: 2021-08-23
journal: Inflamm Bowel Dis
DOI: 10.1093/ibd/izab223
sha: 7936a63355600dcf17d3cbe63c2bca47cf4f0e22
doc_id: 726097
cord_uid: 0nyzw3lw

This letter elucidates the potential novel therapeutic value of electroacupuncture in coronavirus disease 2019 (COVID-19) patients. As a classic treatment of traditional Chinese medicine, electroacupuncture has outstanding effects in the conditioning of gastrointestinal functions for COVID-19 gastrointestinal symptoms.

Dear Editor, I read with great interest an article in your journal about the novel characteristics of gastrointestinal symptoms in inflammatory bowel disease (IBD) patients with coronavirus disease 2019 (COVID-19). 1 IBD is a digestive system disease with gastrointestinal (GI) symptoms as the main symptom, so it is easy to develop new characteristics in parallel with the GI symptoms of COVID-19. We should accurately assess the potential threat of COVID-19 to the GI tract and actively respond to it. It is well known that COVID-19 is a complex, multi-system infection with respiratory system complications as the main symptom. From this perspective, the positive effects of traditional Chinese medicine (TCM) have once again been affirmed in the context of the uncertain risks brought about by the continued spread of the pandemic. In the meantime, it should be noted that electroacupuncture, as the classic treatment of TCM, has outstanding effects in the conditioning of GI functions and is a potential treatment strategy for COVID-19 GI symptoms.

As is known to all, novel coronavirus mainly infects cells through angiotensin converting enzyme II (ACE2) mediation, and digestive tract organs such as the small intestine, appendix, gallbladder, and pancreas all express ACE2 to varying degrees. In other words, the inflammation induced in these digestive organs by a novel coronavirus infection is the main cause of GI symptoms in patients. To the best of our knowledge, diarrhea and vomiting are the most common GI symptoms in COVID-19 patients. The use of TCM to solve GI symptoms in COVID-19 cases suggests that electroacupuncture also has the potential clinical value of regulating GI functions and improving intestinal immunity. Studies have shown that electroacupuncture stimulation of the Zusanli acupoint can significantly reduce GI symptoms caused by severe acute pancreatitis, such as abdominal pain and abdominal distension. [2] [3] [4] This evidence also provides the basis and reference for electroacupuncture treatment of GI symptoms of COVID-19.

As far as we know, electroacupuncture is economical, environmentally friendly, and recyclable. Therefore, with the continuous risk and threat of infection caused by the spread of the pandemic, the potential effects of electroacupuncture as a TCM therapy in alleviating COVID-19 GI symptoms deserves attention. We expect a variety of TCM therapies to play an active role in the prevention and treatment of COVID-19. In addition to raising the possibility of electroacupuncture treatment for COVID-19 GI symptoms, I also call for a large randomized controlled trial to further clarify its potential therapeutic value.

New gastrointestinal symptoms are common in inflammatory bowel disease patients with COVID-19: data from an international registry

Electroacupuncture for severe acute pancreatitis accompanied with paralytic ileus: a randomized controlled trial

Electroacupuncture for treatment of acute pancreatitis and its effect on the intestinal permeability of the patient

Clinical observation on severe acute pancreatitis treated with electroacupuncture at Dachangshu (BL 25) and Shangjuxu (ST 37) combined with ulinastatin